Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 27 studies | 50% ± 26% | |
pericyte | 11 studies | 37% ± 21% | |
myofibroblast cell | 10 studies | 41% ± 22% | |
fibroblast | 4 studies | 26% ± 6% | |
myoepithelial cell | 4 studies | 50% ± 18% | |
muscle cell | 3 studies | 42% ± 17% | |
connective tissue cell | 3 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of CNN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 86% | 49099.67 | 210 / 245 | 99% | 479.00 | 497 / 502 |
bladder | 90% | 98185.00 | 19 / 21 | 61% | 88.47 | 305 / 504 |
intestine | 74% | 105069.99 | 714 / 966 | 69% | 60.97 | 366 / 527 |
uterus | 95% | 89281.32 | 162 / 170 | 43% | 156.20 | 196 / 459 |
esophagus | 75% | 82900.14 | 1087 / 1445 | 58% | 52.43 | 106 / 183 |
stomach | 44% | 40635.02 | 157 / 359 | 76% | 175.98 | 216 / 286 |
blood vessel | 99% | 89031.38 | 1320 / 1335 | 0% | 0 | 0 / 0 |
breast | 25% | 3872.05 | 117 / 459 | 64% | 26.61 | 713 / 1118 |
pancreas | 0% | 0 | 0 / 328 | 82% | 96.12 | 146 / 178 |
lung | 19% | 3022.65 | 112 / 578 | 52% | 76.88 | 605 / 1155 |
ovary | 17% | 5217.09 | 31 / 180 | 36% | 17.16 | 153 / 430 |
kidney | 3% | 378.08 | 3 / 89 | 48% | 22.83 | 433 / 901 |
heart | 38% | 8201.85 | 323 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 163.96 | 2 / 258 | 30% | 13.45 | 68 / 230 |
thymus | 4% | 834.09 | 25 / 653 | 24% | 5.50 | 144 / 605 |
adipose | 16% | 3997.87 | 193 / 1204 | 0% | 0 | 0 / 0 |
skin | 3% | 513.52 | 60 / 1809 | 13% | 2.78 | 59 / 472 |
tonsil | 0% | 0 | 0 / 0 | 16% | 3.91 | 7 / 45 |
liver | 0% | 0 | 0 / 226 | 14% | 3.23 | 58 / 406 |
brain | 0% | 23.06 | 4 / 2642 | 6% | 1.92 | 44 / 705 |
muscle | 1% | 151.78 | 8 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 55.61 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006940 | Biological process | regulation of smooth muscle contraction |
GO_1904706 | Biological process | negative regulation of vascular associated smooth muscle cell proliferation |
GO_0007015 | Biological process | actin filament organization |
GO_0031032 | Biological process | actomyosin structure organization |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005925 | Cellular component | focal adhesion |
GO_0005516 | Molecular function | calmodulin binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CNN1 |
Protein name | Calponin Calponin-1 (Basic calponin) (Calponin H1, smooth muscle) Transgelin Calponin 1 |
Synonyms | |
Description | FUNCTION: Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity (By similarity). . FUNCTION: Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity. . FUNCTION: Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity. . |
Accessions | K7ESJ2 ENST00000588935.1 ENST00000592923.5 ENST00000252456.7 [P51911-1] K7ERK4 ENST00000587087.5 ENST00000585869.1 K7ER02 P51911 K7EQ72 K7ENC5 ENST00000592338.5 ENST00000586577.1 ENST00000586059.5 ENST00000535659.6 K7ERM8 B7Z7E1 |